EUVIMED · CrossrefZeitschrift
Translational Lung Cancer Research
ISSN 2218-6751 · AME Publishing Company
Neueste Artikel
Epigenetics in lung cancer precision medicine: from bench to bedside—a narrative review
Intratumor immune heterogeneity across simulated core biopsy sizes in non-small cell lung cancer: an exploratory study
Cisplatin re-challenge following recovery from carboplatin-induced, biopsy-proven acute tubular necrosis in a 57-year-old patient with squamous-transformed non-small cell lung cancer: a case report
The resistance landscape of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer: molecular mechanisms and novel therapeutic strategies
Methylated circulating tumor DNA: technical challenges and clinical applications in non-small cell lung cancer patients—a narrative review
Cadonilimab induction and consolidation for unresectable stage III non-small cell lung cancer patients receiving concurrent chemoradiation: safety run-in results of a prospective, phase II trial
A radiomics nomogram integrated with radiological features for preoperative prediction of lung nodule invasiveness: comparison with Lung-RADS
Construction and validation of a CT-based radiomics-deep learning signature for non-invasive prediction of PD-L1 expression and immunotherapy outcomes in non-small cell lung cancer
A CT imaging-based deep learning model for predicting EGFR and KRAS mutations in non-small cell lung cancer: toward personalized treatment approaches
Development of a multimodal fully automated ensemble model to predict EGFR mutation and efficacy of EGFR-TKI in non-small cell lung cancer
High GLUT1 protein expression is associated with unfavorable tumor features and poor prognosis in non-small cell lung cancer
A public data-based molecular classification of small cell lung cancer by neuroactive signaling networks unveils distinct microenvironment landscapes and immunotherapy-related prognostic biomarkers
The pathogenesis and therapeutic management of rare pulmonary sarcomatoid carcinoma: a narrative review
Decoding the enigma of multiple primary lung cancers: from mechanism to bedside—a narrative review
Utility of bronchoalveolar lavage in checkpoint inhibitor pneumonitis evaluation: a narrative review
A narrative review of imaging intratumor heterogeneity in non-small cell lung cancer: current advances
The prognostic importance of the pan-immune-inflammation value (PIV) in lung cancer: a systematic review and meta-analysis
Survival after wedge resection, segmentectomy and lobectomy for clinical stage IA non-small cell lung cancer: a systematic review and network meta-analysis
Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory study
Prognostic biomarkers for extensive-stage small cell lung cancer receiving amrubicin following failure of chemoimmunotherapy: a retrospective cohort study
Multimodal prehabilitation to prevent loss of cardiorespiratory fitness in patients with locally advanced lung cancer undergoing chemoimmunotherapy: protocol for a non-randomized multicentre study
Imaging biomarkers related to tumor-associated macrophage in immunotherapy treatment planning for non-small cell lung cancer
Adjuvant chemotherapy before osimertinib in EGFR-mutated stage IB lung adenocarcinoma: a clinical dilemma
Prognostic impact of dose to circulating blood cells in non-small cell lung cancer patients after chemoradiotherapy
Multidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC): 2nd Spanish Lung Cancer Group (GECP) expert consensus statement
Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancer
MicroRNA expression in pleural fluid as a diagnostic biomarker of malignant pleural effusion: promise, pragmatism, and the path forward
Single-cell and spatial analysis reveals macrophage-T cell crosstalk in non-small cell lung cancer immunosuppression
Molecular mechanisms and clinical insights in transformed small cell lung cancer: a narrative review
Current evidence and ongoing trials for surgery versus stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer: a narrative review
EUVIMED